![](https://investorshub.advfn.com/uicon/189332.png?cb=1465554763)
Sunday, February 07, 2016 11:33:53 PM
Alferon is approved, but LDO delivery is experimental. It's an easier pathway..... not to mention a MUCH cheaper option for the large population who may need it.
I will admit to (as yet) not done the background digging on the LDO aspects and potential of HEB for Alferon,... got a link or two or reference you might point me to in order to let me get started more efficiently Johnny?
Regardless of whether it might be Alferon or Ampligen that could be use to push HEB forward,.... Management actually needs to get off their behinds and get the work done to get the job done. That's more the end of this company where I start to get concerned.
The science may be fine,.... their execution of an actual business plan leaves something to be desired.
“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM